- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
HRAS Antibody / HRas Proto-Oncogene GTPase Antibody targets HRAS, a membrane-associated small GTPase and founding member of the RAS family of proto-oncogenes. Originally identified through studies of the Harvey rat sarcoma virus, HRAS is closely related to KRAS and NRAS and functions as a molecular switch controlling signal transmission from activated cell-surface receptors. The HRAS protein cycles between an inactive GDP-bound state and an active GTP-bound state, allowing extracellular signals to regulate proliferation, differentiation, survival and other cellular processes.
Activation of receptor tyrosine kinases and other upstream signaling proteins promotes the exchange of GDP for GTP on HRAS. GTP-bound HRAS interacts with downstream effectors, including RAF kinases, leading to activation of the RAF-MEK-ERK pathway. HRAS also participates in signaling through PI3K-AKT and other effector networks. GTPase-activating proteins normally accelerate GTP hydrolysis and return HRAS to its inactive state, providing an important mechanism for limiting RAS signaling. An HRAS Antibody can therefore support research into RAS pathway activity, growth factor signaling and mechanisms controlling cellular proliferation.
HRAS is a well-established proto-oncogene, and activating mutations can impair normal GTP hydrolysis, resulting in persistent signaling from the GTP-bound protein. Oncogenic HRAS signaling can drive uncontrolled cell growth and transformation through sustained activation of downstream pathways. HRAS mutations have been identified in several tumor types, including cancers of the bladder, thyroid, head and neck, and other tissues. Altered RAS signaling is consequently an important area of cancer biology and targeted therapy research.
Beyond cancer, germline variants affecting HRAS are associated with Costello syndrome, a developmental disorder belonging to the group of conditions known as RASopathies. These findings illustrate the importance of precisely regulated HRAS activity during development as well as in adult tissues. Studies of H-RAS expression, localization and signaling can provide insight into how normal and aberrant RAS activity influences cell fate, proliferation and disease-associated signaling networks.
NSJ Bioreagents provides antibodies for research into RAS signaling, oncogenic pathways and cellular growth regulation. An HRas Proto-Oncogene GTPase Antibody can be used to investigate HRAS expression in studies of RAS/MAPK signaling, cancer biology, growth factor responses and related mechanisms of signal transduction.
HRAS functions as a central molecular switch connecting activated cell-surface receptors with downstream pathways such as RAF-MEK-ERK; explore related signaling targets on our Signal Transduction Antibodies page.
Optimal dilution of the HRAS Antibody / HRas Proto-Oncogene GTPase Antibody should be determined by the researcher.
Amino acids 111-137 (MVLVGNKCDLAARTVESRQAQDLARSY) from the human protein were used as the immunogen for the HRAS antibody.
After reconstitution, the HRAS antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.